Akinobu Hamada
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Papers in
- Oncology 75
- Drug Transport and Resistance Mechanisms 17
- Lung Cancer Research Studies 14
- Colorectal Cancer Treatments and Studies 10
- Cancer Immunotherapy and Biomarkers 10
-
- Lung Cancer Treatments and Mutations 23
- Co-authors
- Hideyuki Saito (34 shared papers)Hiroshi Watanabe (9 shared papers)Masahiro Nakano (7 shared papers)Takashi Shimada (12 shared papers)Noriko Iwamoto (11 shared papers)Kenji Tamura (19 shared papers)Takeo Kawaguchi (5 shared papers)Kan Yonemori (20 shared papers)
- Journals
- Biological and Pharmaceutical Bulletin (14 papers)Annals of Oncology (9 papers)Cancer Science (7 papers)Cancer Chemotherapy and Pharmacology (7 papers)Drug Metabolism and Pharmacokinetics (7 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Akinobu Hamada
168 papers receiving 4.1k citations
Akinobu Hamada's Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 1.5k
- Hematology 325
- Genetics 287
- Pharmacology 199
- Pulmonary and Respiratory Medicine 613
Countries citing papers authored by Akinobu Hamada
This map shows the geographic impact of Akinobu Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akinobu Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akinobu Hamada more than expected).
Fields of papers citing papers by Akinobu Hamada
This network shows the impact of papers produced by Akinobu Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akinobu Hamada. The network helps show where Akinobu Hamada may publish in the future.
Co-authors
The 25 scholars most cited alongside Akinobu Hamada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 173 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. | 2003 | 205 |
| 2 | 2008 | 167 | |
| 3 | 2003 | 138 | |
| 4 | 2014 | 134 | |
| 5 | 2006 | 128 | |
| 6 | 2002 | 102 | |
| 7 | Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial Hit paper breakdown → | 2023 | 101 |
| 8 | 2015 | 96 | |
| 9 | 2007 | 89 | |
| 10 | 2012 | 85 | |
| 11 | 2011 | 84 | |
| 12 | 2011 | 71 | |
| 13 | 2011 | 68 | |
| 14 | 2005 | 67 | |
| 15 | 2009 | 58 | |
| 16 | 2009 | 57 | |
| 17 | 2013 | 56 | |
| 18 | 2008 | 54 | |
| 19 | 2016 | 54 | |
| 20 | 2019 | 54 |
About Akinobu Hamada
Akinobu Hamada is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 173 papers that have together received 4.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Drug Transport and Resistance Mechanisms (17 papers), Lung Cancer Research Studies (14 papers), Cancer therapeutics and mechanisms (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), HIV/AIDS drug development and treatment (12 papers), Colorectal Cancer Treatments and Studies (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Oncology (1.5k citations), Hematology (325 citations), Genetics (287 citations), Pharmacology (199 citations) and Pulmonary and Respiratory Medicine (613 citations). Akinobu Hamada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hideyuki Saito, Hiroshi Watanabe, Masahiro Nakano, Takashi Shimada, Noriko Iwamoto, Kenji Tamura, Takeo Kawaguchi, Kan Yonemori, Takanobu Matsuzaki and Yasuhiro Fujiwara. Their work appears in journals such as Biological and Pharmaceutical Bulletin, Annals of Oncology, Cancer Science, Cancer Chemotherapy and Pharmacology and Drug Metabolism and Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.